2016
DOI: 10.1111/ane.12556
|View full text |Cite
|
Sign up to set email alerts
|

Initial serum thyroid peroxidase antibodies and long-term outcomes in SREAT

Abstract: A correlation between TPO-Ab-titers and outcome has not been reported previously and challenges the notion of a mere bystander role of TPO-Abs in SREAT.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
19
1
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 30 publications
(22 citation statements)
references
References 20 publications
(21 reference statements)
1
19
1
1
Order By: Relevance
“…47 Among all patients, 12.5% have relapses, 12.5% exhibit no response, 3 and 60% are characterized as having a relapsing-remitting courses. 65 Anti-NMDAR encephalitis and other autoimmune encephalitis are considered to be a paraneoplastic syndrome. 25 Initial higher serum TPO-Ab titers associated with more satisfactory outcomes.…”
Section: Prognosismentioning
confidence: 99%
See 1 more Smart Citation
“…47 Among all patients, 12.5% have relapses, 12.5% exhibit no response, 3 and 60% are characterized as having a relapsing-remitting courses. 65 Anti-NMDAR encephalitis and other autoimmune encephalitis are considered to be a paraneoplastic syndrome. 25 Initial higher serum TPO-Ab titers associated with more satisfactory outcomes.…”
Section: Prognosismentioning
confidence: 99%
“…25 Initial higher serum TPO-Ab titers associated with more satisfactory outcomes. 65 Anti-NMDAR encephalitis and other autoimmune encephalitis are considered to be a paraneoplastic syndrome. Whether HE is also a paraneoplastic syndrome is not known.…”
Section: Prognosismentioning
confidence: 99%
“…Isolated elevation of CSF proteins is present in up to 85% of patients, including our patient, suggesting an inflammatory process (1,5), which is further supported by brain biopsies showing lymphocytic perivascular infiltration (5,12). Anti-TPO antibodies have not been demonstrated to play a direct role in the pathogenesis of encephalopathy and are considered merely a marker of autoimmunity (1,2,5), although it is not clear whether higher titers may predict better prognosis as suggested in a recent small trial (13). Thyroid dysfunction itself is not thought to be involved in the pathogenesis of SREAT, as correction of thyroid status alone does not improve encephalopathy (1,5,9).…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, a couple of clinical improvements were shown to be accompanied by a decrease of serum TPO-Ab titers [ 1 , 2 ]. Higher serum TPO-Ab titers were correlated with better outcomes [ 5 ]. However, more long-term clinical observations considering the relationship between clinical outcome and antithyroid autoantibody titers are warranted.…”
Section: Introductionmentioning
confidence: 99%